Min Luo

10PUBLICATIONS

32CO-AUTHORS

Innate immunityMolecular targetsTumour immunologyMedical infection agents (incl. prions)Proteomics and intermolecular interactions (excl. medical proteomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 15, 2026

CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8<sup>+</sup> T cells.

|Apr 14, 2026

Tumor-derived branched-chain α-keto acids activate Notch signaling in tumor-associated macrophages to limit immunity.

Qi-Xiang Ma, Ru Zhao, Jiang-Xue Han

|Mar 30, 2026

Dual function of DOT1L suppresses tumor cell-intrinsic immunogenicity in hepatocellular carcinoma.

Siyuan Xu, Ruijie Gong, Songchen Liu

|Mar 10, 2026

Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling.

Di He, Wenting Zuo, Zhiguang Xiang

|Jan 16, 2026

CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors.

Xianglei Wang, Shiyao Xue, Yuwei Li

|Apr 09, 2025

MYO1F in neutrophils is required for the response to immune checkpoint blockade therapy.

Yingying Qu, Wenhua Liang, Mingzhu Yu

Pageof 2

Frequent Collaborators

Zhigang Lu

Peixuan Zheng

Yun Zhao

Hai Gao

Yingying Qu

Wenhua Liang

Mingzhu Yu

Chenhui Wang

Lin Zhong

Zhigang Li

Frequent Collaborators

Zhigang Lu

Peixuan Zheng

Yun Zhao

Hai Gao